title: Atrial fibrillation: is rate stabilization a valid clinical strategy?
authors.forename: S H
authors.initials: SH
authors.lastname: Hohnloser
mesh_terms: D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000145:classification / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D002985:Clinical Protocols / Q000592:standards*; D004110:Diltiazem / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D009017:Morbidity; D018579:Patient Selection; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D004110:Diltiazem; D000638:Amiodarone